These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1756510)

  • 21. Modification of pancreatic carcinogenesis in the hamster model. XV. Preventive effect of nicotinamide.
    Pour PM; Lawson T
    J Natl Cancer Inst; 1984 Sep; 73(3):767-70. PubMed ID: 6236323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of butylated hydroxyanisole administration on pancreatic carcinogenesis in Syrian hamsters initiated with N-nitrosobis(2-oxopropyl)amine.
    Mizumoto K; Ito S; Kitazawa S; Tsutsumi M; Denda A; Konishi Y
    Carcinogenesis; 1989 Aug; 10(8):1491-4. PubMed ID: 2752523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promotional effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) on N-nitrosobis(2-oxopropyl)amine (BOP)-initiated carcinogenesis in hamsters.
    Furukawa F; Nishikawa A; Enami T; Mitsui M; Imazawa T; Tanakamaru Z; Kim HC; Lee IS; Kasahara K; Takahashi M
    Food Chem Toxicol; 1997; 35(3-4):387-92. PubMed ID: 9207901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
    Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
    Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoting effects of both dietary cholesterol and cholestyramine on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters.
    Ogawa T; Makino T; Kosahara K; Koga A; Nakayama F
    Carcinogenesis; 1992 Nov; 13(11):2047-52. PubMed ID: 1423874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide.
    Meijers M; Appel MJ; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Carcinogenesis; 1992 Sep; 13(9):1525-8. PubMed ID: 1394835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sandostatin, alone and in combination with surgical castration, on pancreatic carcinogenesis in rats and hamsters.
    Visser CJ; van Garderen-Hoetmer A; Klijn JG; Foekens JA
    Int J Cancer; 1996 Mar; 65(6):827-32. PubMed ID: 8631599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
    Ge YC; Morgan RG
    Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK; Permert J; Kazakoff KR; Pour PM; Zuker KA; Bilchik AJ; Adrian TE
    Carcinogenesis; 1993 May; 14(5):1021-6. PubMed ID: 7684953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between goblet cells and carcinoma of the pancreas during N-nitrosobis(2-hydroxypropyl)amine-induced carcinogenesis in Syrian golden hamsters.
    Ishikawa O; Wada A; Oohigashi H; Imaoka S; Iwanaga T
    Cancer Res; 1984 Apr; 44(4):1630-4. PubMed ID: 6200216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogenic effect of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, a postulated proximate pancreatic carcinogen in Syrian hamsters.
    Pour P; Wallcave L; Gingell R; Nagel D; Lawson T; Salmasi S; Tines S
    Cancer Res; 1979 Oct; 39(10):3828-33. PubMed ID: 225009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orotic acid enhancement of preneoplastic and neoplastic lesions induced in the pancreas and liver of hamsters by N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine.
    Kokkinakis DM; Albores-Saavedra J
    Cancer Res; 1994 Oct; 54(20):5324-32. PubMed ID: 7923160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of streptozotocin diabetes on development of nitrosamine-induced pancreatic carcinoma when diabetes induction occurs after nitrosamine exposure.
    Povoski SP; Fenoglio-Preiser CM; Sayers HJ; McCullough PJ; Zhou W; Bell RH
    Carcinogenesis; 1993 May; 14(5):961-7. PubMed ID: 8504490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic endogenous hypercholecystokininemia promotes pancreatic carcinogenesis in the hamster.
    Chu M; Rehfeld JF; Borch K
    Carcinogenesis; 1997 Feb; 18(2):315-20. PubMed ID: 9054623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic lesions in Syrian golden hamsters with pancreatic carcinoma induced by N-nitrosobis(2-oxopropyl)amine (BOP).
    Zalatnai A; Schally AV
    Acta Morphol Hung; 1990; 38(2):119-30. PubMed ID: 2099099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine.
    Pour P; Althoff J; Krüger FW; Mohr U
    J Natl Cancer Inst; 1977 May; 58(5):1449-53. PubMed ID: 857032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a 4-month protocol for the quantitation of BOP-induced lesions in hamster pancreas and its application in studying the effect of dietary fat.
    Woutersen RA; van Garderen-Hoetmer A; Longnecker DS
    Carcinogenesis; 1987 Jun; 8(6):833-7. PubMed ID: 3608081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of octreotide, a somatostatin analogue, on initiation of pancreatic carcinogenesis in hamsters with N-nitrosobis(2-oxopropyl)amine.
    Furukawa F; Nishikawa A; Nakamura H; Miyauchi M; Son H; Hirose M
    Cancer Lett; 2000 Oct; 159(1):43-8. PubMed ID: 10974404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
    Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
    Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.